GlassScriptPhysician profile
Angela D Cheves
NPI 1013560655
$5,329.31
in general payments reported to CMS, 2019-2025
24 companies · $1,364 in 2025
The $1,364 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $625 · 2022: $830 · 2023: $1,259 · 2024: $1,251 · 2025: $1,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,871 · Education: $3.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,871.45 |
| Education | $3.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,474.27 | 2021-2025 | Farxiga, Andexxa, Wainua |
| Pfizer INC. | $504.18 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $481.41 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $420.15 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $395.75 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $356.60 | 2022-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $302.27 | 2022-2025 | Amvuttra, Onpattro |
| Lexicon Pharmaceuticals, INC. | $294.99 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $272.11 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $135.63 | 2021-2024 | Lifevest |
| Esperion Therapeutics, INC. | $120.29 | 2021-2023 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $118.20 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $85.67 | 2022-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $70.34 | 2025 | Uptravi, Opsumit, Opsynvi |
| Innovation Technologies INC | $62.99 | 2025 | Irrisept |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $54.64 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Irhythm Technologies, INC. | $36.47 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Bridgebio Pharma, INC. | $31.40 | 2025 | Attruby |
| Abiomed | $30.55 | 2025 | |
| Amarin Pharma, INC. | $22.14 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.78 | 2024 | |
| Novo Nordisk INC | $16.95 | 2023 | Ozempic, Rybelsus |
| Philips North America LLC | $12.02 | 2022 | |
| Boston Scientific Corporation | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Cheves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.